Role of lipids and lipid signaling in the development of cannabinoid tolerance

Life Sciences

Volumn 77, Issue 14, 2005, Pages 1543-1558

  Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

2 Arachidonoylglycerol; Anandamide; Endocannabinoids; Lipids; Tetrahydrocannabinol; Tolerance

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CARBOXYLIC ACID DERIVATIVE; CERAMIDE; DOPAMINE; ENDOCANNABINOID; FATTY ACID AMIDASE; GLYCEROL; LIPID; N ARACHIDONOYLGLYCINE; OLEAMIDE; PALMIDROL; PROSTAGLANDIN; RECEPTOR SUBTYPE; RIMONABANT; SEROTONIN; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BRAIN REGION; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITION; CONFERENCE PAPER; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; HUMAN; LIGAND BINDING; LIPID METABOLISM; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; OBESITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

CANNABINOIDS; DRUG TOLERANCE; ENDOCANNABINOIDS; HUMANS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

ANIMALIA; CANNABIS SATIVA;

EID: 23044476443     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.005     Document Type: Conference Paper

References (135)

1. G. Arreaza, W.A. Devane, R.L. Omeir, G. Sajnani, J. Kunz, B.F. Cravatt, and D.G. Deutsch The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine Neuroscience Letters 234 1997 59 62
2. S.C. Azad, K. Monory, G. Marsicano, B.F. Cravatt, B. Lutz, W. Zieglgansberger, and G. Rammes Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling Journal of Neuroscience 24 2004 9953 9961
3. D. Baker, G. Pryce, J.L. Croxford, P. Brown, R.G. Pertwee, A. Makriyannis, A. Khanolkar, L. Layward, F. Fezza, T. Bisogno, and V. Di Marzo Endocannabinoids control spasticity in a multiple sclerosis model FASEB Journal 15 2001 300 302
4. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neuroscience and Biobehavioral Reviews 16 1992 55 62
5. C.E. Bass, and B.R. Martin Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice Drug and Alcohol Dependence 60 2000 113 119
6. 1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells Molecular Pharmacology 63 2003 908 914
7. S. Ben-Shabat, E. Fride, T. Sheskin, T. Tamiri, M.H. Rhee, Z. Vogel, T. Bisogno, L. De Petrocellis, V. Di Marzo, and R. Mechoulam An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity European Journal of Pharmacology 353 1998 23 31
8. E.M. Berry, and R. Mechoulam Tetrahydrocannabinol and endocannabinoids in feeding and appetite Pharmacology and Therapeutics 95 2002 185 190
9. V. Bezuglov, M. Bobrov, N. Gretskaya, A. Gonchar, G. Zinchenko, D. Melck, T. Bisogno, V. Di Marzo, D. Kuklev, J.C. Rossi, J.P. Vidal, and T. Durand Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine Bioorganic and Medicinal Chemistry Letters 11 2001 447 449
10. 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands British Journal of Pharmacology 48 1973 169 171
11. T. Bisogno, D. Melck, M. Bobrov, N.M. Gretskaya, V.V. Bezuglov, L. De Petrocellis, and V. Di Marzo N-Acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Biochemical Journal 351 2000 817 824
12. T. Bisogno, F. Howell, G. Williams, A. Minassi, M.G. Cascio, A. Ligresti, I. Matias, A. Schiano-Moriello, P. Paul, E.J. Williams, U. Gangadharan, C. Hobbs, V. Di Marzo, and P. Doherty Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain Journal of Cell Biology 163 2003 463 468
13. S.C. Black Cannabinoid receptor antagonists and obesity Current Opinion in Investigational Drugs 5 2004 389 394
14. C. Blazquez, C. Sanchez, A. Daza, I. Galve-Roperh, and M. Guzman The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme Journal of Neurochemistry 72 1999 1759 1768
15. D.L. Boger, S.J. Henriksen, and B.F. Cravatt Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules Current Pharmaceutical Design 4 1998 303 314
16. 9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain Journal of Neurochemistry 1999 73
17. C.S. Breivogel, G. Griffin, V. Di Marzo, and B.R. Martin Evidence for a new G protein-coupled cannabinoid receptor in mouse brain Molecular Pharmacology 60 2001 155 163
18. S.H. Burstein, S.M. Huang, T.J. Petros, R.G. Rossetti, J.M. Walker, and R.B. Zurier Regulation of anandamide tissue levels by N-arachidonylglycine Biochemical Pharmacology 64 2002 1147 1150
19. D. Centonze, N. Battista, S. Rossi, N.B. Mercuri, A. Finazzi-Agro, G. Bernardi, P. Calabresi, and M. Maccarrone A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission Neuropsychopharmacology 29 2004 1488 1497
20. C.J. Chu, S.M. Huang, L. De Petrocellis, T. Bisogno, S.A. Ewing, J.D. Miller, R.E. Zipkin, N. Daddario, G. Appendino, V. Di Marzo, and J.M. Walker N-Oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia Journal of Biological Chemistry 278 2003 13633 13639
21. B. Colasanti, C. Lindamood, and C. Craig Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats Pharmacology, Biochemistry and Behavior 16 1982 573 578
22. D.R. Compton, W.L. Dewey, and B.R. Martin Cannabis dependence and tolerance production C.K. Erickson M.A. Javors W.W. Morgan Addiction Potential of Abused Drugs and Drug Classes 1990 The Hayworth Press, Inc. Binghampton, N.Y. 129 147
23. D.R. Compton, K.C. Rice, B.R. De Costa, R.K. Razdan, L.S. Melvin, M.R. Johnson, and B.R. Martin Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities Journal of Pharmacology and Experimental Therapeutics 265 1993 218 226
24. S. Conti, B. Costa, M. Colleoni, D. Parolaro, and G. Giagnoni Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat British Journal of Pharmacology 135 2002 181 187
25. 1 receptors in hippocampal neurons Journal of Neuroscience 21 2001 2425 2433
26. L. De Petrocellis, D. Melck, T. Bisogno, and V. Di Marzo Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders Chemistry and Physics of Lipids 108 2000 191 209
27. 1 receptors FEBS Letters 506 2001 253 256
28. W.A. Devane, F.A. Dysarz, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Molecular Pharmacology 34 1988 605 613
29. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
30. 9-tetrahydrocannabinol Biochemical Pharmacology 22 1973 399 405
31. V. Di Marzo, T. Bisogno, D. Melck, R. Ross, H. Brockie, L. Stevenson, R. Pertwee, and L. De Petrocellis Interactions between synthetic vanilloids and the endogenous cannabinoid system FEBS Letters 436 1998 449 454
32. V. Di Marzo, F. Berrendero, T. Bisogno, S. Gonzalez, P. Cavaliere, J. Romero, M. Cebeira, J.A. Ramos, and J.J. Fernandez-Ruiz Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta-9-tetrahydrocannabinol-tolerant rats Journal of Neurochemistry 74 2000 1627 1635
33. V. Di Marzo, T. Bisogno, L. De Petrocellis, I. Brandi, R.G. Jefferson, R.L. Winckler, J.B. Davis, O. Dasse, A. Mahadevan, R.K. Razdan, and B.R. Martin Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands Biochemical and Biophysical Research Communication 281 2001 444 451
34. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Batkai, Z. Jarai, F. Fezza, G.I. Miura, R.D. Palmiter, T. Sugiura, and G. Kunos Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
35. V. Di Marzo, D. Melck, P. Orlando, T. Bisogno, O. Zagoory, M. Bifulco, Z. Vogel, and L. De Petrocellis Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells Biochemistry Journal 358 2001 249 255
36. M. Diana, M. Melis, A.L. Muntoni, and G.L. Gessa Mesolimbic dopaminergic decline after cannabinoid withdrawal Proceedings of the National Academy of Sciences of the United States of America 95 1998 10269 10273
37. M.A. Diana, C. Levenes, K. Mackie, and A. Marty Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids Journal of Neuroscience 22 2002 200 208
38. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, S.L. Sensi, S. Kathuria, and D. Piomelli Brain monoglyceride lipase participating in endocannabinoid inactivation Proceedings of the National Academy of Sciences of the United States of America 99 2002 10819 10824
39. 1 receptor in rat brain Proceedings of the Royal Society of London. Series B, Biological Sciences 265 1998 2081 2085
40. M. Egertova, B.F. Cravatt, and M.R. Elphick Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling Neuroscience 119 2003 481 496
41. 9-THC, CP 55,940 and WIN 55,212 Journal of Pharmacology and Experimental Therapeutics 271 1994 1383 1390
42. W.P. Farquhar-Smith, and A.S. Rice Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder Anesthesiology 94 2001 507 513
43. C.C. Felder, K. Joyce, E.M. Briley, J. Mansouri, K. Mackie, O. Blond, Y. Lai, A. Ma, and R. Mitchell Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors Molecular Pharmacology 48 1995 443 450
44. 1 but not opioid receptors Neuroscience Letters 226 1997 159 162
45. E. Fride, and R. Mechoulam Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent European Journal of Pharmacology 231 1993 313 314
46. G.L. Gerdeman, J.G. Partridge, C.R. Lupica, and D.M. Lovinger It could be habit forming: drugs of abuse and striatal synaptic plasticity Trends in Neuroscience 26 2003 184 192
47. C.M. Gérard, C. Mollereau, G. Vassart, and M. Parmentier Molecular cloning of a human cannabinoid receptor which is also expressed in testis Biochemistry Journal 279 1991 129 134
48. S. Gonzalez, M.G. Cascio, J. Fernandez-Ruiz, F. Fezza, V. Di Marzo, and J.A. Ramos Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine Brain Research 954 2002 73 81
49. S. Gonzalez, J. Fernandez-Ruiz, V. Di Marzo, M. Hernandez, C. Arevalo, C. Nicanor, M.G. Cascio, E. Ambrosio, and J.A. Ramos Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9- tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence Drug and Alcohol Dependence 74 2004 159 170
50. A.I. Gulyas, B.F. Cravatt, M.H. Bracey, T.P. Dinh, D. Piomelli, F. Boscia, and T.F. Freund Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala European Journal of Neuroscience 20 2004 441 458
51. M. Guzman, and C. Sanchez Effects of cannabinoids on energy metabolism Life Sciences 65 1999 657 664
52. M. Guzman, I. Galve-Roperh, and C. Sanchez Ceramide: a new second messenger of cannabinoid action Trends in Pharmacological Sciences 22 2001 19 22
53. J.C. Halford Clinical pharmacotherapy for obesity: current drugs and those in advanced development Current Drug Targets 5 2004 637 646
54. L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R.G. Pertwee, R.A. Ross, R. Mechoulam, and E. Fride HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor Proceedings of the National Academy of Sciences of the United States of America 96 1999 14228 14233
55. 1 receptor Proceedings of the National Academy of Sciences of the United States of America 98 2001 3662 3665
56. C.L. Hart, A.S. Ward, M. Haney, S.D. Comer, R.W. Foltin, and M.W. Fischman Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans Psychopharmacology (Berlin) 164 2002 407 415
57. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. DeCosta, and K.C. Rice Cannabinoid receptor localization in the brain Proceedings of the National Academy of Sciences of the United States of America 87 1990 1932 1936
58. C.R. Hiley, and W.R. Ford Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling Biological Reviews of the Cambridge Philosophical Society 79 2004 187 205
59. A.F. Hoffman, and C.R. Lupica Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus Journal of Neuroscience 20 2000 2470 2479
60. A.F. Hoffman, and C.R. Lupica Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids Journal of Neurophysiology 85 2001 72 83
61. 2 receptors suppresses hyperalgesia evoked by intradermal capsaicin Journal of Pharmacology and Experimental Therapeutics 308 2004 446 453
62. T.L. Horvath Endocannabinoids and the regulation of body fat: the smoke is clearing Journal of Clinical Investigation 112 2003 323 326
63. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology: XXVII. Classification of cannabinoid receptors Pharmacological Reviews 54 2002 161 202
64. 1 cannabinoid receptor Journal of Neurochemistry 73 1999 493 501
65. S.M. Huang, T. Bisogno, T.J. Petros, S.Y. Chang, P.A. Zavitsanos, R.E. Zipkin, R. Sivakumar, A. Coop, D.Y. Maeda, L. De Petrocellis, S. Burstein, V. Di Marzo, and J.M. Walker Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain Journal of Biological Chemistry 276 2001 42639 42644
66. 1 receptors Proceedings of the National Academy of Sciences of the United States of America 99 2002 8400 8405
67. 2 receptor Bioorganic & Medicinal Chemistry 7 1999 2905 2914
68. 2 ligand palmitoylethanolamide, prevents the viscero-visceral hyperreflexia associated with inflammation of the rat urinary bladder Neuroscience Letters 253 1998 123 126
69. 1 cannabinoid receptor mediate desensitization and internalization Journal of Neuroscience 19 1999 3773 3780
70. 9-tetrahydrocannabinol and other cannabinoids Life Sciences 15 1974 931 947
71. R. Karler, L.D. Calder, and S.A. Turkanis C.W. Sharp Mechanisms of Tolerance and Dependence, NIDA Research Monograph Series 54 1984 Government Printing Office Washington, D.C. 312 322
72. S. Kaymakcalan Tolerance to and dependence on cannabis Bulletin of Narcotics 25 1973 39 47
73. M. Kouznetsova, B. Kelley, M. Shen, and S.A. Thayer Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture Molecular Pharmacology 61 2002 477 485
74. A.C. Kreitzer, and W.G. Regehr Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids Journal of Neuroscience 21 2001 RC174
75. D.M. Lambert, F.G. DiPaolo, P. Sonveaux, M. Kanyonyo, S.J. Govaerts, E. Hermans, J. Bueb, N.M. Delzenne, and E.J. Tschirhart Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors Biochimica and Biophysica Acta 1440 1999 266 274
76. 1 neurons of the rat hippocampus in vitro Brain Research 997 2004 1 14
77. J. Li, N.E. Kaminski, and D.H. Wang Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor Hypertension 41 2003 757 762
78. A.H. Lichtman SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats European Journal of Pharmacology 404 2000 175 179
79. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism Psychopharmacology 126 1996 125 131
80. A.H. Lichtman, S.A. Varvel, and B.R. Martin Endocannabinoids in cognition and dependence Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 269 285
81. C.R. Lupica, A.C. Riegel, and A.F. Hoffman Marijuana and cannabinoid regulation of brain reward circuits British Journal of Pharmacology 143 2004 227 234
82. K. Mackie, and B. Hille Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells Proceedings of the National Academy of Sciences of the United States of America 89 1992 3825 3829
83. K. Mackie, Y. Lai, R. Westenbroek, and R. Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor Journal of Neuroscience 15 1995 6552 6561
84. T.P. Malan, M.M. Ibrahim, T.W. Vanderah, A. Makriyannis, and F. Porreca Inhibition of pain responses by activation of CB(2) cannabinoid receptors Chemistry and Physics of Lipids 121 2002 191 200
85. 1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
86. 9-tetrahydrocannabinol in mice D.J. Harvey Marihuana '84, Proceedings of the Oxford Symposium on Cannabis, Oxford 1985 685 692
87. B.R. Martin, and A.H. Lichtman Cannabinoid transmission and pain perception Neurobiology of Disease 5 1998 447 461
88. 9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs Journal of Pharmacology and Experimental Therapeutics 196 1976 128 144
89. W.J. Martin, C.M. Loo, and A.I. Basbaum Spinal cannabinoids are anti-allodynic in rats with persistent inflammation Pain 82 1999 199 205
90. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
91. 9-trans-tetrahydrocannabinol in pigeons: tolerance to the behavioral effects Science 169 1970 501 503
92. D.E. McMillan, W.L. Dewey, and L.S. Harris Characteristics of tetrahydrocannabinol tolerance Annals of the New York Academy of Science 191 1971 83 99
93. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N. Kaminski, A. Schatz, A. Gopher, S. Almog, B. Martin, D. Compton, R. Pertwee, G. Griffin, M. Bayewitch, J. Barg, and Z. Vogel Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochemical Pharmacology 50 1995 83 90
94. R. Mechoulam, E. Fride, and V. Di Marzo Endocannabinoids European Journal of Pharmacology 359 1998 1 18
95. 9-tetrahydrocannabinol in rats Psychopharmacology 67 1980 195 202
96. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 64
97. Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda Molecular characterization of a phospholipase d generating anandamide and its congeners Journal of Biological Chemistry 279 2004 5298 5305
98. A. Oviedo, J. Glowa, and M. Herkenham Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study Brain Research 616 1993 293 302
99. 1- tetrahydrocannabinol British Journal of Pharmacology 51 1974 391 397
100. R.G. Pertwee Tolerance to and dependence on psychotropic cannabinoids J.A. Pratt The Biological Bases of Drug Tolerance and Dependence 1991 Academic Press New York 231 263
101. R.G. Pertwee Cannabinoid receptors and pain Progress in Neurobiology 63 2001 569 611
102. H.G. Pope Jr. Cannabis, cognition, and residual confounding Journal of the American Medical Association 287 2002 1172 1174
103. H. Pope, and D. Yurgelun-Todd The residual cognitive effects of heavy marijuana use in college students Journal of the American Medical Association 275 1996 521 527
104. H.G. Pope, A.J. Gruber, J.I. Hudson, G. Cohane, M.A. Huestis, and D. Yurgelun-Todd Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence 69 2003 303 310
105. 2 cannabinoid receptors Anesthesiology 99 2003 955 960
106. M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J.C. Brelière, and G. Le Fur SR141716A, a potent and selective antagonist of the brain cannabinoid receptor Federation of European Biochemical Societies Letters 350 1994 240 244
107. 2 cannabinoid receptor Journal of Pharmacology and Experimental Therapeutics 284 1998 644 650
108. 9-tetrahydrocannabinol treatment Pharmacology, Biochemistry and Behavior 47 1994 33 40
109. C. Sanchez, D. Rueda, B. Segui, I. Galve-Roperh, T. Levade, and M. Guzman The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan Molecular Pharmacology 59 2001 955 959
110. 35S]thio) triphosphate binding in rat brain membranes Life Sciences 59 1996 659 668
111. 2): identification of cannabinoid receptor subtype selective ligands Journal of Pharmacology and Experimental Therapeutics 278 1996 989 999
112. 1- tetrahydrocannabinol by rats tolerant to cannabis Canadian Journal of Physiology and Pharmacology 52 1974 1154 1166
113. 9-tetrahydrocannabinol on cannabinoid receptor adaptation in mice Journal of Pharmacology and Experimental Therapeutics 303 2002 36 44
114. P.B. Smith, D.R. Compton, S.P. Welch, R.K. Razdan, R. Mechoulam, and B.R. Martin The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice Journal of Pharmacology and Experimental Therapeutics 270 1994 219 227
115. 1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats Journal of Pharmacology and Experimental Therapeutics 306 2003 93 102
116. N. Solowij, P. Michie, and A. Fox Differential impairments of selective attention due to frequency and duration of cannabis use Biological Psychiatry 37 1995 731 739
117. B. Szabo, L. Dorner, C. Pfreundtner, W. Norenberg, and K. Starke Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum Neuroscience 85 1998 395 403
118. B. Szabo, T. Muller, and H. Koch Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro Journal of Neurochemistry 73 1999 1084 1089
119. 9-tetrahydrocannabinol in rhesus monkeys Toxicology and Applied Pharmacology 27 1974 648 665
120. S. Vandevoorde, K.O. Jonsson, C.J. Fowler, and D.M. Lambert Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide Journal of Medicinal Chemistry 46 2003 1440 1448
121. S.A. Varvel, R.J. Hamm, B.R. Martin, and A.H. Lichtman Differential effects of delta 9-THC on spatial reference and working memory in mice Psychopharmacology (Berlin) 157 2001 142 150
122. D. Vigano, M. Valenti, M.G. Cascio, V. Di Marzo, D. Parolaro, and T. Rubino Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine European Journal of Neuroscience 20 2004 1849 1857
123. 1 cannabinoid receptor stimulation Behavioural Brain Research 141 2003 215 222
124. K. Walker, A.J. Fox, and L.A. Urban Animal models for pain research Molecular Medicine Today 5 1999 319 321
125. J.M. Walker, N.M. Strangman, and S.M. Huang Cannabinoids and pain Pain Research and Management 6 2001 74 79
126. 1 receptors in cannabinoid anticonvulsant effects European Journal of Pharmacology 428 2001 51 57
127. M. Wallace, B. Martin, and R. DeLorenzo Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity European Journal of Pharmacology 452 2002 295
128. M.J. Wallace, R.E. Blair, K.W. Falenski, B.R. Martin, and R.J. DeLorenzo The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy Journal of Pharmacology and Experimental Therapeutics 307 2003 129 137
129. L. Wang, J. Liu, J. Harvey-White, A. Zimmer, and G. Kunos Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice Proceedings of the National Academy of Sciences of the United States of America 100 2003 1393 1398
130. A. Weber, J. Ni, K.H. Ling, A. Acheampong, D.D. Tang-Liu, R. Burk, B.F. Cravatt, and D. Woodward Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry Journal of Lipid Research 45 2004 757 763
131. A. Wikler Aspects of tolerance to and dependence on cannabis Annals of the New York Academy of Science 282 1976 126 147
132. J.L. Wiley, and B.R. Martin Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes Chemistry and Physics of Lipids 121 2002 57 63
133. J.L. Wiley, I.D. Beletskaya, E.W. Ng, Z. Dai, P.J. Crocker, A. Mahadevan, R.K. Razdan, and B.R. Martin Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists Journal of Pharmacology and Experimental Therapeutics 301 2002 679 689
134. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 2001 588 592
135. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682